Q: How do I get involved?

Whether you’re a researcher, journalist, developer, or longevity enthusiast, we welcome your participation. Email us at contact@longevityone.org to explore partnerships, media opportunities, or to join our contributor network.

Question 1

What is LongevityOne?

Accepted Answer

LongevityOne is a global platform dedicated to curing human aging. We consolidate advanced research, emerging technology, and unified data to accelerate innovation in the longevity space. Our mission is to serve scientists, bio-hackers, and advocates with trustworthy resources and collaborative tools.

Question 2

Who founded LongevityOne?

Accepted Answer

LongevityOne was founded by Michael Peres, a serial entrepreneur and biomedical researcher with a background in Mathematics, Computer Science, and Jewish Studies. He is currently pursuing Biomedical Engineering to strengthen the technical foundation of LongevityOne’s work. Learn more about him at michaelperes.com.

Question 3

What makes LongevityOne different?

Accepted Answer

We don’t just report on breakthroughs — we unify them. LongevityOne acts as a central repository where research, news, tools, and contributors converge. By removing silos in the aging research ecosystem, we accelerate progress toward reversing age-related decline.

Question 4

Who is LongevityOne for?

Accepted Answer

Our platform is built for:Researchers in biotechnology, genetics, and agingMedical professionals and institutionsBio-hackers and health optimizersInvestors in life-extension technologiesPublic advocates for healthy aging

Question 5

What are your long-term goals?

Accepted Answer

Our core objective is to contribute to the development of a foundational cure for aging. We aim to reshape the human experience of aging by supporting breakthrough research, increasing public understanding, and fostering international collaboration over the next 15 years.

Question 6

How do I get involved?

Accepted Answer

Whether you&#8217;re a researcher, journalist, developer, or longevity enthusiast, we welcome your participation. Email us at contact@longevityone.org to explore partnerships, media opportunities, or to join our contributor network.

This Strange Particle May Hold Clues to the Universe’s Biggest Secrets

These Massive Stars 10,000x Heavier Than the Sun Ruled Early Universe

Scientists Unlock a Hidden Side of Light That Could Transform Technology

JWST Reveals a 3D Map of a Planet So Hot It Destroys Water

Scientists Solve Yellow Fever Mystery with Unprecedented High-Resolution 3D Images

“Rotten Egg” Gas Could Be the Surprising Cure for Nail Infections

Ultra-Processed Foods Linked to Alarming Differences in Brain Structure

Hair Loss

How Oral and Topical Minoxidil Compare for Hair Loss Treatment

Precision DNA Profiling for Next Generation Hair Loss Solutions

The DHT Story in Hair Loss-Still True, but PGD2 Writes a Missing Chapter

Contributors+

Investing in longevity biotech talent

Synchron lands $200m to commercialize ‘thought control’ technology

Tech that empowers, not replaces

Jupiter Neurosciences receives FDA clearance to begin Phase 2a trial of JOTROL in Parkinson’s disease

Neurona Therapeutics receives EMA PRIME designation for NRTX-1001 in drug-resistant focal epilepsy

Serina Therapeutics faces clinical hold on its SER-252 Parkinson’s program

Omada Health to present real-world GLP-1 insights at ObesityWeek 2025

Sky Labs secures investment from Omron subsidiary OMRON Ventures

Category 3